Female gender and oral anticoagulants are associated with wound complications in lower extremity vein bypass: An analysis of 1404 operations for critical limb ischemia
Background Infrainguinal bypass (IB) surgery is an effective means of improving arterial circulation to the lower extremity for patients with critical limb ischemia (CLI). However, wound complications (WC) of the surgical incision following IB can impart significant morbidity. Methods A retrospectiv...
Gespeichert in:
Veröffentlicht in: | Journal of vascular surgery 2007-12, Vol.46 (6), p.1191-1197.e1 |
---|---|
Hauptverfasser: | , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 1197.e1 |
---|---|
container_issue | 6 |
container_start_page | 1191 |
container_title | Journal of vascular surgery |
container_volume | 46 |
creator | Nguyen, Louis L., MD, MBA, MPH Brahmanandam, Soma, MD Bandyk, Dennis F., MD Belkin, Michael, MD Clowes, Alexander W., MD Moneta, Gregory L., MD Conte, Michael S., MD |
description | Background Infrainguinal bypass (IB) surgery is an effective means of improving arterial circulation to the lower extremity for patients with critical limb ischemia (CLI). However, wound complications (WC) of the surgical incision following IB can impart significant morbidity. Methods A retrospective analysis of WC from the 1404 patients enrolled in a multicenter clinical trial of vein bypass grafting for CLI was performed. Univariate and multivariable regression models were used to determine WC predictors and associated outcomes, including graft patency, limb salvage, quality of life (QoL), resource utilization (RU), and mortality. Results A total of 543 (39%) patients developed a reported WC within 30 days of surgery, with infections (284, 52%) and hematoma/hemorrhage (121, 22%) being the most common type. Postoperative anticoagulation (odds ratio [OR], 1.554; 95% confidence interval [CI] 1.202 to 2.009; P = .0008) and female gender (OR, 1.376; 95% CI, 1.076 to 1.757; P = .0108) were independent factors associated with WC. Primary, primary-assisted, and secondary graft patency rates were not influenced by the presence of WC; though, patients with WC were at increased risk for limb loss (hazard ratio [HR], 1.511; 95% CI 1.096 to 2.079; P = .0116) and higher mortality (HR, 1.449; 95% CI 1.098 to 1.912; P = .0089). WC was not significantly associated with lower QoL at 3 months (4.67 vs 4.79, P = .1947) and 12 months (5.02 vs 5.13, P = .2806). However, the subset of patients with serious WC (SWC) demonstrated significantly lower QoL at 3 months compared with patients without WC, (4.43 vs 4.79, respectively, P = .0166), though this difference was not seen at 12 months (4.94 vs 5.13, P = .2411). Patients with WC had higher RU than patients who did not have WC. Mean index length of hospital stay (LOS) was 2.3 days longer, mean cumulative 1-year LOS was 8.1 days longer, and mean number of hospitalizations was 0.5 occurrences greater for patients with WC compared with patients without WC (all P < .0001). Conclusions WC is a frequent complication of IB for CLI, associated with increased risk for major amputation, mortality, and greater RU. Further detailed investigation into the link between female gender and oral anticoagulation use with WC may help identify causes of WC and perhaps prevent or lessen their occurrence. |
doi_str_mv | 10.1016/j.jvs.2007.07.053 |
format | Article |
fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_2929600</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0741521407012803</els_id><sourcerecordid>69083859</sourcerecordid><originalsourceid>FETCH-LOGICAL-c534t-ef6b54a2b0680e26d26758d6eb89fd5e8aa693d08cfb1e0db03488e254fc2cd83</originalsourceid><addsrcrecordid>eNp9UsGO0zAQjRCILQsfwAX5AreWsRMnDkgrrVYsIK3EAThbjj1pXZK42ElLv4jfZKJWLHBAsmTLfu_NzHvOsuccVhx4-Xq72u7TSgBUq3nJ_EG24FBXy1JB_TBbQFXwpRS8uMiepLQF4Fyq6nF2wRWXRV3LRfbzFnvTIVvj4DAyMzgWounoMHobzHrq6JSYichMSsF6M6JjBz9u2CFMhLah33XemtGHITE_sC4cSAh_jBF7Px7ZHumyOe6I_oZdD6RsumPyiYWW8QIKFnYYz_Q2RGajp9LUQuf7hvlkN6RjnmaPWtMlfHbeL7Ovt---3HxY3n16__Hm-m5pZV6MS2zLRhZGNEAWoCidKCupXImNqlsnURlT1rkDZduGI7gG8kIpFLJorbBO5ZfZ1Ul3NzU9OovDSHboXfS9iUcdjNd_vwx-o9dhr0Ut6hKABF6dBWL4PmEadU8zYEc-YpiSLmtQuZI1AfkJaGNIKWL7uwgHPcert5ri1XO8el4yJ86LP7u7Z5zzJMDLM8Ak8rCNZrA-3eMIQ_PPY7494ZC83HuMOlmPg0XnI9pRu-D_28bVP2zb-WEO7RseMW3DFCnkpLlOQoP-PP_D-RtCBVwoyPNfEVDdBQ</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>69083859</pqid></control><display><type>article</type><title>Female gender and oral anticoagulants are associated with wound complications in lower extremity vein bypass: An analysis of 1404 operations for critical limb ischemia</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals</source><source>EZB Electronic Journals Library</source><creator>Nguyen, Louis L., MD, MBA, MPH ; Brahmanandam, Soma, MD ; Bandyk, Dennis F., MD ; Belkin, Michael, MD ; Clowes, Alexander W., MD ; Moneta, Gregory L., MD ; Conte, Michael S., MD</creator><creatorcontrib>Nguyen, Louis L., MD, MBA, MPH ; Brahmanandam, Soma, MD ; Bandyk, Dennis F., MD ; Belkin, Michael, MD ; Clowes, Alexander W., MD ; Moneta, Gregory L., MD ; Conte, Michael S., MD</creatorcontrib><description>Background Infrainguinal bypass (IB) surgery is an effective means of improving arterial circulation to the lower extremity for patients with critical limb ischemia (CLI). However, wound complications (WC) of the surgical incision following IB can impart significant morbidity. Methods A retrospective analysis of WC from the 1404 patients enrolled in a multicenter clinical trial of vein bypass grafting for CLI was performed. Univariate and multivariable regression models were used to determine WC predictors and associated outcomes, including graft patency, limb salvage, quality of life (QoL), resource utilization (RU), and mortality. Results A total of 543 (39%) patients developed a reported WC within 30 days of surgery, with infections (284, 52%) and hematoma/hemorrhage (121, 22%) being the most common type. Postoperative anticoagulation (odds ratio [OR], 1.554; 95% confidence interval [CI] 1.202 to 2.009; P = .0008) and female gender (OR, 1.376; 95% CI, 1.076 to 1.757; P = .0108) were independent factors associated with WC. Primary, primary-assisted, and secondary graft patency rates were not influenced by the presence of WC; though, patients with WC were at increased risk for limb loss (hazard ratio [HR], 1.511; 95% CI 1.096 to 2.079; P = .0116) and higher mortality (HR, 1.449; 95% CI 1.098 to 1.912; P = .0089). WC was not significantly associated with lower QoL at 3 months (4.67 vs 4.79, P = .1947) and 12 months (5.02 vs 5.13, P = .2806). However, the subset of patients with serious WC (SWC) demonstrated significantly lower QoL at 3 months compared with patients without WC, (4.43 vs 4.79, respectively, P = .0166), though this difference was not seen at 12 months (4.94 vs 5.13, P = .2411). Patients with WC had higher RU than patients who did not have WC. Mean index length of hospital stay (LOS) was 2.3 days longer, mean cumulative 1-year LOS was 8.1 days longer, and mean number of hospitalizations was 0.5 occurrences greater for patients with WC compared with patients without WC (all P < .0001). Conclusions WC is a frequent complication of IB for CLI, associated with increased risk for major amputation, mortality, and greater RU. Further detailed investigation into the link between female gender and oral anticoagulation use with WC may help identify causes of WC and perhaps prevent or lessen their occurrence.</description><identifier>ISSN: 0741-5214</identifier><identifier>EISSN: 1097-6809</identifier><identifier>DOI: 10.1016/j.jvs.2007.07.053</identifier><identifier>PMID: 18154995</identifier><identifier>CODEN: JVSUES</identifier><language>eng</language><publisher>New York, NY: Mosby, Inc</publisher><subject>Administration, Oral ; Aged ; Aged, 80 and over ; Anticoagulants - administration & dosage ; Anticoagulants - adverse effects ; Biological and medical sciences ; Blood and lymphatic vessels ; Cardiology. Vascular system ; Cardiovascular Agents - therapeutic use ; Dermatology ; Diseases of the peripheral vessels. Diseases of the vena cava. Miscellaneous ; Extremities - blood supply ; Female ; Graft Occlusion, Vascular - etiology ; Health Care Costs ; Health Resources - utilization ; Hematoma - economics ; Hematoma - epidemiology ; Hematoma - etiology ; Humans ; Incidence ; Ischemia - drug therapy ; Ischemia - economics ; Ischemia - mortality ; Ischemia - physiopathology ; Ischemia - surgery ; Limb Salvage ; Male ; Medical sciences ; Middle Aged ; North America ; Odds Ratio ; Oligonucleotides - therapeutic use ; Postoperative Hemorrhage - economics ; Postoperative Hemorrhage - epidemiology ; Postoperative Hemorrhage - etiology ; Quality of Life ; Retrospective Studies ; Risk Assessment ; Risk Factors ; Sex Factors ; Skin involvement in other diseases. Miscellaneous. General aspects ; Surgery ; Surgery (general aspects). Transplantations, organ and tissue grafts. Graft diseases ; Surgical Wound Infection - economics ; Surgical Wound Infection - epidemiology ; Surgical Wound Infection - etiology ; Transplantation, Autologous ; Treatment Outcome ; Vascular Patency ; Vascular surgery: aorta, extremities, vena cava. Surgery of the lymphatic vessels ; Vascular Surgical Procedures - adverse effects ; Vascular Surgical Procedures - economics ; Vascular Surgical Procedures - methods ; Veins - transplantation</subject><ispartof>Journal of vascular surgery, 2007-12, Vol.46 (6), p.1191-1197.e1</ispartof><rights>The Society for Vascular Surgery</rights><rights>2007 The Society for Vascular Surgery</rights><rights>2008 INIST-CNRS</rights><rights>Copyright © 2007 by The Society for Vascular Surgery. 2007</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c534t-ef6b54a2b0680e26d26758d6eb89fd5e8aa693d08cfb1e0db03488e254fc2cd83</citedby><cites>FETCH-LOGICAL-c534t-ef6b54a2b0680e26d26758d6eb89fd5e8aa693d08cfb1e0db03488e254fc2cd83</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.sciencedirect.com/science/article/pii/S0741521407012803$$EHTML$$P50$$Gelsevier$$Hfree_for_read</linktohtml><link.rule.ids>230,314,776,780,881,3537,27901,27902,65306</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=19956938$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/18154995$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Nguyen, Louis L., MD, MBA, MPH</creatorcontrib><creatorcontrib>Brahmanandam, Soma, MD</creatorcontrib><creatorcontrib>Bandyk, Dennis F., MD</creatorcontrib><creatorcontrib>Belkin, Michael, MD</creatorcontrib><creatorcontrib>Clowes, Alexander W., MD</creatorcontrib><creatorcontrib>Moneta, Gregory L., MD</creatorcontrib><creatorcontrib>Conte, Michael S., MD</creatorcontrib><title>Female gender and oral anticoagulants are associated with wound complications in lower extremity vein bypass: An analysis of 1404 operations for critical limb ischemia</title><title>Journal of vascular surgery</title><addtitle>J Vasc Surg</addtitle><description>Background Infrainguinal bypass (IB) surgery is an effective means of improving arterial circulation to the lower extremity for patients with critical limb ischemia (CLI). However, wound complications (WC) of the surgical incision following IB can impart significant morbidity. Methods A retrospective analysis of WC from the 1404 patients enrolled in a multicenter clinical trial of vein bypass grafting for CLI was performed. Univariate and multivariable regression models were used to determine WC predictors and associated outcomes, including graft patency, limb salvage, quality of life (QoL), resource utilization (RU), and mortality. Results A total of 543 (39%) patients developed a reported WC within 30 days of surgery, with infections (284, 52%) and hematoma/hemorrhage (121, 22%) being the most common type. Postoperative anticoagulation (odds ratio [OR], 1.554; 95% confidence interval [CI] 1.202 to 2.009; P = .0008) and female gender (OR, 1.376; 95% CI, 1.076 to 1.757; P = .0108) were independent factors associated with WC. Primary, primary-assisted, and secondary graft patency rates were not influenced by the presence of WC; though, patients with WC were at increased risk for limb loss (hazard ratio [HR], 1.511; 95% CI 1.096 to 2.079; P = .0116) and higher mortality (HR, 1.449; 95% CI 1.098 to 1.912; P = .0089). WC was not significantly associated with lower QoL at 3 months (4.67 vs 4.79, P = .1947) and 12 months (5.02 vs 5.13, P = .2806). However, the subset of patients with serious WC (SWC) demonstrated significantly lower QoL at 3 months compared with patients without WC, (4.43 vs 4.79, respectively, P = .0166), though this difference was not seen at 12 months (4.94 vs 5.13, P = .2411). Patients with WC had higher RU than patients who did not have WC. Mean index length of hospital stay (LOS) was 2.3 days longer, mean cumulative 1-year LOS was 8.1 days longer, and mean number of hospitalizations was 0.5 occurrences greater for patients with WC compared with patients without WC (all P < .0001). Conclusions WC is a frequent complication of IB for CLI, associated with increased risk for major amputation, mortality, and greater RU. Further detailed investigation into the link between female gender and oral anticoagulation use with WC may help identify causes of WC and perhaps prevent or lessen their occurrence.</description><subject>Administration, Oral</subject><subject>Aged</subject><subject>Aged, 80 and over</subject><subject>Anticoagulants - administration & dosage</subject><subject>Anticoagulants - adverse effects</subject><subject>Biological and medical sciences</subject><subject>Blood and lymphatic vessels</subject><subject>Cardiology. Vascular system</subject><subject>Cardiovascular Agents - therapeutic use</subject><subject>Dermatology</subject><subject>Diseases of the peripheral vessels. Diseases of the vena cava. Miscellaneous</subject><subject>Extremities - blood supply</subject><subject>Female</subject><subject>Graft Occlusion, Vascular - etiology</subject><subject>Health Care Costs</subject><subject>Health Resources - utilization</subject><subject>Hematoma - economics</subject><subject>Hematoma - epidemiology</subject><subject>Hematoma - etiology</subject><subject>Humans</subject><subject>Incidence</subject><subject>Ischemia - drug therapy</subject><subject>Ischemia - economics</subject><subject>Ischemia - mortality</subject><subject>Ischemia - physiopathology</subject><subject>Ischemia - surgery</subject><subject>Limb Salvage</subject><subject>Male</subject><subject>Medical sciences</subject><subject>Middle Aged</subject><subject>North America</subject><subject>Odds Ratio</subject><subject>Oligonucleotides - therapeutic use</subject><subject>Postoperative Hemorrhage - economics</subject><subject>Postoperative Hemorrhage - epidemiology</subject><subject>Postoperative Hemorrhage - etiology</subject><subject>Quality of Life</subject><subject>Retrospective Studies</subject><subject>Risk Assessment</subject><subject>Risk Factors</subject><subject>Sex Factors</subject><subject>Skin involvement in other diseases. Miscellaneous. General aspects</subject><subject>Surgery</subject><subject>Surgery (general aspects). Transplantations, organ and tissue grafts. Graft diseases</subject><subject>Surgical Wound Infection - economics</subject><subject>Surgical Wound Infection - epidemiology</subject><subject>Surgical Wound Infection - etiology</subject><subject>Transplantation, Autologous</subject><subject>Treatment Outcome</subject><subject>Vascular Patency</subject><subject>Vascular surgery: aorta, extremities, vena cava. Surgery of the lymphatic vessels</subject><subject>Vascular Surgical Procedures - adverse effects</subject><subject>Vascular Surgical Procedures - economics</subject><subject>Vascular Surgical Procedures - methods</subject><subject>Veins - transplantation</subject><issn>0741-5214</issn><issn>1097-6809</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2007</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9UsGO0zAQjRCILQsfwAX5AreWsRMnDkgrrVYsIK3EAThbjj1pXZK42ElLv4jfZKJWLHBAsmTLfu_NzHvOsuccVhx4-Xq72u7TSgBUq3nJ_EG24FBXy1JB_TBbQFXwpRS8uMiepLQF4Fyq6nF2wRWXRV3LRfbzFnvTIVvj4DAyMzgWounoMHobzHrq6JSYichMSsF6M6JjBz9u2CFMhLah33XemtGHITE_sC4cSAh_jBF7Px7ZHumyOe6I_oZdD6RsumPyiYWW8QIKFnYYz_Q2RGajp9LUQuf7hvlkN6RjnmaPWtMlfHbeL7Ovt---3HxY3n16__Hm-m5pZV6MS2zLRhZGNEAWoCidKCupXImNqlsnURlT1rkDZduGI7gG8kIpFLJorbBO5ZfZ1Ul3NzU9OovDSHboXfS9iUcdjNd_vwx-o9dhr0Ut6hKABF6dBWL4PmEadU8zYEc-YpiSLmtQuZI1AfkJaGNIKWL7uwgHPcert5ri1XO8el4yJ86LP7u7Z5zzJMDLM8Ak8rCNZrA-3eMIQ_PPY7494ZC83HuMOlmPg0XnI9pRu-D_28bVP2zb-WEO7RseMW3DFCnkpLlOQoP-PP_D-RtCBVwoyPNfEVDdBQ</recordid><startdate>20071201</startdate><enddate>20071201</enddate><creator>Nguyen, Louis L., MD, MBA, MPH</creator><creator>Brahmanandam, Soma, MD</creator><creator>Bandyk, Dennis F., MD</creator><creator>Belkin, Michael, MD</creator><creator>Clowes, Alexander W., MD</creator><creator>Moneta, Gregory L., MD</creator><creator>Conte, Michael S., MD</creator><general>Mosby, Inc</general><general>Elsevier</general><scope>6I.</scope><scope>AAFTH</scope><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>20071201</creationdate><title>Female gender and oral anticoagulants are associated with wound complications in lower extremity vein bypass: An analysis of 1404 operations for critical limb ischemia</title><author>Nguyen, Louis L., MD, MBA, MPH ; Brahmanandam, Soma, MD ; Bandyk, Dennis F., MD ; Belkin, Michael, MD ; Clowes, Alexander W., MD ; Moneta, Gregory L., MD ; Conte, Michael S., MD</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c534t-ef6b54a2b0680e26d26758d6eb89fd5e8aa693d08cfb1e0db03488e254fc2cd83</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2007</creationdate><topic>Administration, Oral</topic><topic>Aged</topic><topic>Aged, 80 and over</topic><topic>Anticoagulants - administration & dosage</topic><topic>Anticoagulants - adverse effects</topic><topic>Biological and medical sciences</topic><topic>Blood and lymphatic vessels</topic><topic>Cardiology. Vascular system</topic><topic>Cardiovascular Agents - therapeutic use</topic><topic>Dermatology</topic><topic>Diseases of the peripheral vessels. Diseases of the vena cava. Miscellaneous</topic><topic>Extremities - blood supply</topic><topic>Female</topic><topic>Graft Occlusion, Vascular - etiology</topic><topic>Health Care Costs</topic><topic>Health Resources - utilization</topic><topic>Hematoma - economics</topic><topic>Hematoma - epidemiology</topic><topic>Hematoma - etiology</topic><topic>Humans</topic><topic>Incidence</topic><topic>Ischemia - drug therapy</topic><topic>Ischemia - economics</topic><topic>Ischemia - mortality</topic><topic>Ischemia - physiopathology</topic><topic>Ischemia - surgery</topic><topic>Limb Salvage</topic><topic>Male</topic><topic>Medical sciences</topic><topic>Middle Aged</topic><topic>North America</topic><topic>Odds Ratio</topic><topic>Oligonucleotides - therapeutic use</topic><topic>Postoperative Hemorrhage - economics</topic><topic>Postoperative Hemorrhage - epidemiology</topic><topic>Postoperative Hemorrhage - etiology</topic><topic>Quality of Life</topic><topic>Retrospective Studies</topic><topic>Risk Assessment</topic><topic>Risk Factors</topic><topic>Sex Factors</topic><topic>Skin involvement in other diseases. Miscellaneous. General aspects</topic><topic>Surgery</topic><topic>Surgery (general aspects). Transplantations, organ and tissue grafts. Graft diseases</topic><topic>Surgical Wound Infection - economics</topic><topic>Surgical Wound Infection - epidemiology</topic><topic>Surgical Wound Infection - etiology</topic><topic>Transplantation, Autologous</topic><topic>Treatment Outcome</topic><topic>Vascular Patency</topic><topic>Vascular surgery: aorta, extremities, vena cava. Surgery of the lymphatic vessels</topic><topic>Vascular Surgical Procedures - adverse effects</topic><topic>Vascular Surgical Procedures - economics</topic><topic>Vascular Surgical Procedures - methods</topic><topic>Veins - transplantation</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Nguyen, Louis L., MD, MBA, MPH</creatorcontrib><creatorcontrib>Brahmanandam, Soma, MD</creatorcontrib><creatorcontrib>Bandyk, Dennis F., MD</creatorcontrib><creatorcontrib>Belkin, Michael, MD</creatorcontrib><creatorcontrib>Clowes, Alexander W., MD</creatorcontrib><creatorcontrib>Moneta, Gregory L., MD</creatorcontrib><creatorcontrib>Conte, Michael S., MD</creatorcontrib><collection>ScienceDirect Open Access Titles</collection><collection>Elsevier:ScienceDirect:Open Access</collection><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Journal of vascular surgery</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Nguyen, Louis L., MD, MBA, MPH</au><au>Brahmanandam, Soma, MD</au><au>Bandyk, Dennis F., MD</au><au>Belkin, Michael, MD</au><au>Clowes, Alexander W., MD</au><au>Moneta, Gregory L., MD</au><au>Conte, Michael S., MD</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Female gender and oral anticoagulants are associated with wound complications in lower extremity vein bypass: An analysis of 1404 operations for critical limb ischemia</atitle><jtitle>Journal of vascular surgery</jtitle><addtitle>J Vasc Surg</addtitle><date>2007-12-01</date><risdate>2007</risdate><volume>46</volume><issue>6</issue><spage>1191</spage><epage>1197.e1</epage><pages>1191-1197.e1</pages><issn>0741-5214</issn><eissn>1097-6809</eissn><coden>JVSUES</coden><abstract>Background Infrainguinal bypass (IB) surgery is an effective means of improving arterial circulation to the lower extremity for patients with critical limb ischemia (CLI). However, wound complications (WC) of the surgical incision following IB can impart significant morbidity. Methods A retrospective analysis of WC from the 1404 patients enrolled in a multicenter clinical trial of vein bypass grafting for CLI was performed. Univariate and multivariable regression models were used to determine WC predictors and associated outcomes, including graft patency, limb salvage, quality of life (QoL), resource utilization (RU), and mortality. Results A total of 543 (39%) patients developed a reported WC within 30 days of surgery, with infections (284, 52%) and hematoma/hemorrhage (121, 22%) being the most common type. Postoperative anticoagulation (odds ratio [OR], 1.554; 95% confidence interval [CI] 1.202 to 2.009; P = .0008) and female gender (OR, 1.376; 95% CI, 1.076 to 1.757; P = .0108) were independent factors associated with WC. Primary, primary-assisted, and secondary graft patency rates were not influenced by the presence of WC; though, patients with WC were at increased risk for limb loss (hazard ratio [HR], 1.511; 95% CI 1.096 to 2.079; P = .0116) and higher mortality (HR, 1.449; 95% CI 1.098 to 1.912; P = .0089). WC was not significantly associated with lower QoL at 3 months (4.67 vs 4.79, P = .1947) and 12 months (5.02 vs 5.13, P = .2806). However, the subset of patients with serious WC (SWC) demonstrated significantly lower QoL at 3 months compared with patients without WC, (4.43 vs 4.79, respectively, P = .0166), though this difference was not seen at 12 months (4.94 vs 5.13, P = .2411). Patients with WC had higher RU than patients who did not have WC. Mean index length of hospital stay (LOS) was 2.3 days longer, mean cumulative 1-year LOS was 8.1 days longer, and mean number of hospitalizations was 0.5 occurrences greater for patients with WC compared with patients without WC (all P < .0001). Conclusions WC is a frequent complication of IB for CLI, associated with increased risk for major amputation, mortality, and greater RU. Further detailed investigation into the link between female gender and oral anticoagulation use with WC may help identify causes of WC and perhaps prevent or lessen their occurrence.</abstract><cop>New York, NY</cop><pub>Mosby, Inc</pub><pmid>18154995</pmid><doi>10.1016/j.jvs.2007.07.053</doi><tpages>7</tpages><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0741-5214 |
ispartof | Journal of vascular surgery, 2007-12, Vol.46 (6), p.1191-1197.e1 |
issn | 0741-5214 1097-6809 |
language | eng |
recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_2929600 |
source | MEDLINE; Elsevier ScienceDirect Journals; EZB Electronic Journals Library |
subjects | Administration, Oral Aged Aged, 80 and over Anticoagulants - administration & dosage Anticoagulants - adverse effects Biological and medical sciences Blood and lymphatic vessels Cardiology. Vascular system Cardiovascular Agents - therapeutic use Dermatology Diseases of the peripheral vessels. Diseases of the vena cava. Miscellaneous Extremities - blood supply Female Graft Occlusion, Vascular - etiology Health Care Costs Health Resources - utilization Hematoma - economics Hematoma - epidemiology Hematoma - etiology Humans Incidence Ischemia - drug therapy Ischemia - economics Ischemia - mortality Ischemia - physiopathology Ischemia - surgery Limb Salvage Male Medical sciences Middle Aged North America Odds Ratio Oligonucleotides - therapeutic use Postoperative Hemorrhage - economics Postoperative Hemorrhage - epidemiology Postoperative Hemorrhage - etiology Quality of Life Retrospective Studies Risk Assessment Risk Factors Sex Factors Skin involvement in other diseases. Miscellaneous. General aspects Surgery Surgery (general aspects). Transplantations, organ and tissue grafts. Graft diseases Surgical Wound Infection - economics Surgical Wound Infection - epidemiology Surgical Wound Infection - etiology Transplantation, Autologous Treatment Outcome Vascular Patency Vascular surgery: aorta, extremities, vena cava. Surgery of the lymphatic vessels Vascular Surgical Procedures - adverse effects Vascular Surgical Procedures - economics Vascular Surgical Procedures - methods Veins - transplantation |
title | Female gender and oral anticoagulants are associated with wound complications in lower extremity vein bypass: An analysis of 1404 operations for critical limb ischemia |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-01T06%3A58%3A50IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Female%20gender%20and%20oral%20anticoagulants%20are%20associated%20with%20wound%20complications%20in%20lower%20extremity%20vein%20bypass:%20An%20analysis%20of%201404%20operations%20for%20critical%20limb%20ischemia&rft.jtitle=Journal%20of%20vascular%20surgery&rft.au=Nguyen,%20Louis%20L.,%20MD,%20MBA,%20MPH&rft.date=2007-12-01&rft.volume=46&rft.issue=6&rft.spage=1191&rft.epage=1197.e1&rft.pages=1191-1197.e1&rft.issn=0741-5214&rft.eissn=1097-6809&rft.coden=JVSUES&rft_id=info:doi/10.1016/j.jvs.2007.07.053&rft_dat=%3Cproquest_pubme%3E69083859%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=69083859&rft_id=info:pmid/18154995&rft_els_id=S0741521407012803&rfr_iscdi=true |